Amplitude (AMPL) Insider Notice: 7,500 Shares to Be Sold via Morgan Stanley

Rhea-AI Filing Summary

Form 144 filed for Amplitude, Inc. (AMPL) discloses a proposed sale of 7,500 common shares through Morgan Stanley Smith Barney with an aggregate market value of $85,200.00, to be sold on 08/15/2025 on NASDAQ. The filing states these shares were acquired by exercise of stock options on 08/15/2025 and paid in cash. The filer previously executed 10b5-1 plan sales of 7,500 shares on 07/15/2025 26,394 shares on 06/11/2025

Insights

Securities Analyst

TL;DR: Routine Form 144 insider sale post-option exercise; amounts disclosed but not clearly material to company metrics.

The filing documents a proposed sale of 7,500 common shares acquired by option exercise on the same date, with sale routed through Morgan Stanley on NASDAQ. Two prior 10b5-1 plan sales in June and July 2025 are disclosed with gross proceeds. This pattern is consistent with planned insider liquidations under trading plans rather than ad hoc disposals. The filing contains transaction dates, amounts, and proceeds but does not provide context about percentage ownership or relation to outstanding insider holdings, limiting assessment of materiality.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 and 10b5-1 reporting; no indicia of undisclosed material information.

The notice includes the required representation regarding lack of undisclosed material adverse information and references reliance on a 10b5-1 plan for prior sales. Signature and attestation language are present. The document does not include the filers identity details in the provided excerpt or the filers remaining beneficial ownership stake, which are important for governance assessment. Based on available text, this appears to be a standard compliance filing rather than a governance red flag.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7500	85200.00	102111652	08/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Exercise of Stock Options	Issuer			7500	08/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ERICA F SCHULTZ 201 Third Street, Suite 200 San Francisco CA 94103	COMMON	07/15/2025	7500	94205.25
10b5-1 Sales for ERICA F SCHULTZ 201 Third Street, Suite 200 San Francisco CA 94103	COMMON	06/11/2025	26394	329731.49

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for AMPL disclose?

The filing discloses a proposed sale of 7,500 common shares $85,200.00) to be sold on 08/15/2025 on NASDAQ.

How were the shares acquired for the AMPL Form 144 sale?

The shares were acquired by exercise of stock options on 08/15/2025 and paid for in cash.

Were there prior related sales by the same person?

Yes. The filer documented 10b5-1 plan sales of 26,394 shares on 06/11/2025 $329,731.49) and 7,500 shares on 07/15/2025 $94,205.25).

Which broker and exchange are involved in the proposed sale?

The broker is Morgan Stanley Smith Barney LLC and the proposed sale is listed on NASDAQ.

Does the filing state whether the sale relies on a 10b5-1 plan?

The filing references prior 10b5-1 sales in the past three months; the current proposed sale table does not explicitly state a plan adoption date in the provided excerpt.